Relmada Therapeutics, Inc. RLMD Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $9.78M+180% | $3.5M+153% | $1.38M+2.3% | $1.35M+17.7% | $1.15M-70.2% | ||
| $224.19M+150% | $89.51M+616% | $12.5M-35.1% | $19.27M-25.6% | $25.91M-36.9% | ||
| $235.34M+150% | $93.98M+533% | $14.85M-29.6% | $21.09M-23.7% | $27.66M-39.6% | ||
| —— | $3.54M— | —— | —— | —— | ||
| $235.36M+150% | $94M+532% | $14.88M-29.6% | $21.12M-23.7% | $27.68M-39.6% | ||
| $5.73M+265% | $1.57M+8.0% | $1.45M+6.7% | $1.36M+7.7% | $1.27M-69.4% | ||
| $12.89M+100% | $6.43M+23.9% | $5.19M+1.1% | $5.13M-1.9% | $5.23M-49.2% | ||
| $16.63M+122% | $7.49M+38.5% | $5.41M+4.7% | $5.17M-1.4% | $5.24M-49.1% | ||
| 150M0.0% | 150M0.0% | 150M0.0% | 150M0.0% | 150M0.0% | ||
| -$717.32M-2.7% | -$698.27M-2.9% | -$678.4M-1.5% | -$668.31M-1.5% | -$658.44M-2.7% | ||
| $218.73M+153% | $86.51M+814% | $9.47M-40.7% | $15.95M-28.9% | $22.44M-36.8% | ||
| $235.36M+150% | $94M+532% | $14.88M-29.6% | $21.12M-23.7% | $27.68M-39.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Relmada Therapeutics, Inc.'s total assets?
- Relmada Therapeutics, Inc. (RLMD) holds $235.4M in total assets, up 750.3% year over year.
- How much cash does Relmada Therapeutics, Inc. have?
- Relmada Therapeutics, Inc. holds $9.8M in cash and equivalents.
- Can Relmada Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 18.26 — current assets exceed current liabilities.
- Where does Relmada Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Relmada Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.